Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.
about
Drug safety surveillance using de-identified EMR and claims data: issues and challengesClinical research informatics: a conceptual perspectiveComputational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworksMultilingual Medical Data Models in ODM Format: A Novel Form-based Approach to Semantic Interoperability between Routine Healthcare and Clinical ResearchHarmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR projectManaging data quality for a drug safety surveillance system.Signal detection and monitoring based on longitudinal healthcare dataA common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical recordsFeasibility and utility of applications of the common data model to multiple, disparate observational health databases.Exploring a structural protein-drug interactome for new therapeutics in lung cancerValidation of a common data model for active safety surveillance research.The use of observational health-care data to identify and report on off-label use of biopharmaceutical products.Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes.Cross border semantic interoperability for clinical research: the EHR4CR semantic resources and servicesDesiderata for computable representations of electronic health records-driven phenotype algorithms.Improving postapproval drug safety surveillance: getting better information soonerBiobanking informatics infrastructure to support clinical and translational research.ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS.Clinical element models in the SHARPn consortium.A nursing information model process for interoperability.Integrated precision medicine: the role of electronic health records in delivering personalized treatment.Computational Drug Repositioning Using Continuous Self-Controlled Case SeriesPrognosis of Clinical Outcomes with Temporal Patterns and Experiences with One Class Feature Selection.Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.A Semantic Transformation Methodology for the Secondary Use of Observational Healthcare Data in Postmarketing Safety Studies.CDEGenerator: an online platform to learn from existing data models to build model registries
P2860
Q28385191-0A58DDC1-896B-4963-9E95-A2ECC17BF2C2Q28386227-0912C0FB-EAA1-4B5E-BE5E-7A19BDCF5AADQ28651547-CCD39AD1-31A4-460E-82AC-94EE08910433Q28709437-DC2EFA33-0129-4E93-BF78-6D02DBC8DD47Q28709512-CDD80BB8-7DD0-42A0-B41B-DEE39234420EQ30685299-EA1D2DC3-8FC8-43BD-9C5E-51C5B2E23E87Q30706851-6CD2E8FB-3BA0-4D06-9C46-7D3B6F8A10C6Q30886141-D71D53FB-0B48-404E-A2C4-B6BAC4D1FE95Q30891288-726B0792-4408-4215-B709-B29CB0A95129Q33593907-03DFE6E2-31C6-436C-B890-F578FBE73CF4Q34061613-36E0BECF-FF27-4C2D-9DF7-C263E1597DE8Q34219300-55E3ED47-DE01-4D79-8F54-74A1C82B5A26Q34226785-E920BB05-62C7-4E93-83B8-C2AAF9683B7DQ34553415-1ABC97DD-8964-4D85-8234-66B4D60EF6A8Q35914408-5E0B4525-9D99-4888-9F5E-93C6E11B616BQ36115616-3A59261B-6EC2-49CB-B9F5-0490D9C54163Q36265667-716FDAD1-9A9E-477B-8921-0C3C2FE38D1DQ36367834-54609351-A38A-4425-A436-8B880DC8D298Q37354337-54B6B84F-CD64-484E-94B0-818D3A34CDE6Q37354400-8F9FF657-995C-4F3A-99B6-ADF072C3ED73Q38400158-BF86C4CD-EBFB-42C7-82BA-FF239A22A0DAQ38416691-7041729D-D5E5-4096-88B0-19EFB05D3E6CQ38756680-CAE559F9-561D-4D71-8FD5-680A2A93289AQ38895303-FE77B6F6-2487-482E-A141-462CB33DFBBFQ39589840-95CEA61F-1ADA-406A-9D2C-B4A70477CEB0Q44301592-A574BA1D-5866-4C6D-973C-D4937B88E2DCQ52705350-C5311FD5-80A4-49C6-A8B5-F668FC3B5257Q55109610-E380C879-2820-4F8D-8978-7A183589058FQ58790649-74A9FE31-3832-41E0-A67F-F0527936AE70
P2860
Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development and evaluation of ...... isparate healthcare databases.
@ast
Development and evaluation of ...... isparate healthcare databases.
@en
type
label
Development and evaluation of ...... isparate healthcare databases.
@ast
Development and evaluation of ...... isparate healthcare databases.
@en
prefLabel
Development and evaluation of ...... isparate healthcare databases.
@ast
Development and evaluation of ...... isparate healthcare databases.
@en
P2093
P2860
P1476
Development and evaluation of ...... isparate healthcare databases.
@en
P2093
Donald J O'Hara
Edward N Pattishall
Gregory E Powell
Jeffery L Painter
Jonathan A Morris
Patrick B Ryan
Stephanie J Reisinger
P2860
P304
P356
10.1136/JAMIA.2009.002477
P577
2010-11-01T00:00:00Z